Financial models
Search documents
First Negative S&P 500 Signals As Mega Tech Breaks Down From October Highs
Seeking Alpha· 2026-02-04 17:03
If you are looking for an incredible community to apply proven financial models ranging from Dividends, to Breakout picks, to ETFs, and Long Term Value consistently beating the markets with double digit returns, then join our outstanding members at Value & Momentum BreakoutsThis article serves as a brief January recap and a forecast into February. Some records were set in January that may be the first to have ever happened in my lifetime. As February begins we have some precariousJD Henning is a Finance PhD ...
Stocks Are Overvalued, Expect Losses And Low 10-Year Forward Returns: Update October 2025
Seeking Alpha· 2025-11-06 20:37
Group 1 - Georg Vrba, a professional engineer, believes that mathematical models offer superior guidance on market direction compared to financial experts [1] - Vrba has developed financial models for various markets including the stock market, bond market, yield curve, gold, silver, and recession prediction, with updates provided weekly at iMarketSignals [1]
Hims & Hers: Strong Q1 Masks Problematic Long-Term Value Proposition
Seeking Alpha· 2025-05-06 14:16
Group 1 - The marketplace channel Haggerston BioHealth offers exclusive stock tips focused on Pharma, Biotech, and Healthcare, providing access to investment bank-grade financial models and research [1] - The group caters to both novice and experienced biotech investors, offering insights on catalysts, buy and sell ratings, product sales forecasts, and integrated financial statements [2] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group and has compiled detailed reports on over 1,000 companies [2]
Tandem Diabetes Q4 Earnings Review: I Don't Share The Market's Skepticism
Seeking Alpha· 2025-02-27 17:44
Group 1 - The marketplace channel Haggerston BioHealth offers exclusive stock tips focused on Pharma, Biotech, and Healthcare, providing access to investment bank-grade financial models and research [1] - The group caters to both novice and experienced biotech investors, offering insights on catalysts, buy and sell ratings, product sales forecasts, and integrated financial statements [2] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group and has compiled detailed reports on over 1,000 companies [2]